MedTrace Logo

OxSYPan: Oxford Study With Young People on Antidepressants

NCT03436173 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2018-02-20

No results posted yet for this study

Summary

Fluoxetine is commonly used to treat adolescent depression, but the neural mechanisms underlying antidepressant drugs in the young brain are still poorly understood. This study proposes to investigate the effects of a single dose of fluoxetine on emotional neural processing in a sample of depressed adolescents, using functional Magnetic Resonance Imaging (fMRI).

Conditions

Interventions

DRUG

Fluoxetine

Fluoxetine 10 mg/2.5 ml mixed with water

OTHER

Peppermint syrup

Liquid peppermint syrup measured to the equivalent volume and mixed with water

Sponsors & Collaborators

  • University of Oxford

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
13 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-05-23
Primary Completion
2015-11-10
Completion
2015-11-10

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03436173 on ClinicalTrials.gov